TD Waterhouse Canada
FHTX icon

TD Waterhouse Canada’s Foghorn Therapeutics FHTX Stock Holding History

TD Waterhouse Canada’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.93K Hold
1,000
– – ﹤0.01% 2129
2026
Q2 		$5.01K Buy
+1,000
New +$4.44K ﹤0.01% 1977

Other funds holding FHTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

TD Waterhouse Canada's FHTX Position: Q3 2026 in Review

TD Waterhouse Canada held its Foghorn Therapeutics (FHTX) position steady in Q3 2026 at 1,000 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

TD Waterhouse Canada first reported a position in FHTX in Q2 2026 and has held it in 2 quarters since. The position peaked at $5.01K in Q2 2026. 40 funds tracked by Wall St. Rank hold FHTX as of Q3 2026.

  • TD Waterhouse Canada held 1,000 shares of Foghorn Therapeutics worth $2.93K as of Q3 2026.
  • TD Waterhouse Canada left its Foghorn Therapeutics share count unchanged in Q3 2026.
  • Foghorn Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q3 2026, its #2129 holding.
  • TD Waterhouse Canada first reported a position in Foghorn Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • TD Waterhouse Canada's Foghorn Therapeutics position peaked at $5.01K in Q2 2026.
  • 40 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q3 2026.

Based on TD Waterhouse Canada's 13F filing for Q3 2026, filed 16 Oct 2026.